SEC Form 4 · accession 0001179110-17-012323
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Craig Barrows
Officer — Executive VP, General Counsel
Period of report
Sep 13, 2017
Accepted (ET)
Sep 15, 2017 · 3:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 13, 2017 | M | 20,000 | $4.50 | A | 51,100 | D | |
| Common StockF2 | Sep 13, 2017 | S | 14,600 | $6.9455 | D | 36,500 | D | |
| Common Stock | Sep 15, 2017 | M | 30,000 | $4.50 | A | 66,500 | D | |
| Common StockF2 | Sep 15, 2017 | S | 22,450 | $6.7284 | D | 44,050 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.50 | Sep 13, 2017 | M | 20,000 | D | Oct 3, 2008 | Oct 3, 2017 | Common Stock | 20,000 | 30,000 | D |
| Stock Option (right to buy)F1 | $4.50 | Sep 15, 2017 | M | 30,000 | D | Oct 3, 2008 | Oct 3, 2017 | Common Stock | 30,000 | 0 | D |
Explanation of responses
- F1Exercisable as to 12,500 shares commencing on October 3, 2008, 12,500 shares commencing on October 3, 2009, 12,500 shares commencing on October 3, 2010 and 12,500 shares commencing on October 3, 2011.
- F2Weighted average price of shares sold.